Introduction
Healthcare organisations' growth strategies are often built around new patient acquisition. Advertising budgets, performance campaigns, lead flows and appointment conversions are kept in the foreground. In contrast, retaining existing patients often remains a quieter, later-noticed and therefore secondary domain. Yet the data shows this approach produces a structural blind spot. Clinics are acquiring new patients, but in most cases they are not keeping them long enough.
Research findings reveal that patient retention is not only a matter of satisfaction or loyalty; it is directly linked to profitability, lifetime value and growth efficiency. The real issue is not how many new patients a clinic wins, but what share of them it can preserve into the second, third and subsequent interactions. Because in healthcare, sustainable profitability is shaped less by high-volume acquisition and more by strong retention.
1. The Sector's Structural Paradox: Growth Exists, Net Gain Does Not
Source: Buxton — "many organisations lose patients faster than they acquire them"
One of the most striking data points is the imbalance between growth and loss rates in healthcare. According to a Buxton analysis, the average healthcare organisation has a new-patient growth rate of 45% while its patient loss rate sits at 48%. In other words, many organisations are losing patients faster than they acquire them. In that condition, visible growth does not produce genuine base expansion; it becomes a cycle that merely finances standing still.
A similar picture is seen at the patient database level. Physicians lose roughly half of their patient database within five years on average. The fact that 36% of existing patients have switched their healthcare provider in the last two years shows that this churn structure is not an exception but a widespread behavioural pattern. That the average retention rate after five years falls to 43% — and that the average retention rate in dentistry stays at only 41% — clarifies just how fragile patient relationships are.
For this reason, the sense of being "busy" and real growth are not the same thing. The patient pool may appear to be expanding; but if it is not retained, profitability stays under pressure.
2. Why Is Acquiring a New Patient More Expensive?
The clearest area where the link between retention and profitability appears is the cost structure. Acquiring a new patient is 5 to 25 times more expensive than retaining an existing one. Although it varies by specialty, the average patient acquisition cost ranges from $240 to $461. In dental, this figure is about $385; in cosmetic and plastic surgery, it can rise to $610. Retention costs, in contrast, remain at only 15–25% of acquisition cost.
Probability of showing up for the next appointment — Artisan Strategies, 2025
Combined with patient behaviour data, this cost gap becomes even more meaningful. An established existing patient has a 60–70% probability of attending their next appointment, while a new patient has only a 5–20% probability of completing a second visit. In other words, clinics are both paying more to acquire patients and seeing a lower probability that those patients will return. An existing patient, meanwhile, carries a higher return probability at lower cost.
In this framing, retention is a revenue-protection mechanism with a higher return on investment. Acquisition is, of course, necessary; but when retention is weak, the acquisition budget becomes progressively less efficient.
3. How Does Retention Grow Profitability?
One of the strongest findings is the disproportionate effect of small increases in retention on profitability. According to the model derived from Bain & Company research and validated across many sectors including healthcare, a 5% increase in retention rate can boost profitability by 25% to 95%. Even if this effect is considered more conservative in healthcare, the direction does not change: small retention gains create large financial differences.
"Protecting a small but loyal patient base is often more valuable than large-scale new-patient campaigns."
At a more granular level, every 1% increase in short-term retention increases patient lifetime value by 4%. In a five-year perspective, every 1% change in annual retention rate produces a 2% increase in value.
The Pareto effect is also critical here. 20% of existing patients produce about 80% of future profit. For this reason, protecting a small but loyal patient base is often more valuable than large-scale new-patient campaigns.
4. Why Should Patient Lifetime Value Be One of the Core Metrics?
To read the retention–profitability relationship correctly, patient lifetime value (PLV) becomes a central metric. The fact that the average patient lifetime value in general healthcare is estimated at $12,000–$15,000 shows that a single patient carries significantly more economic weight than is often assumed.
In dentistry, basic calculations range from $2,100 to $6,000, while with restorative or cosmetic procedures and referral effects added, this value can climb to $4,500–$22,000. Membership-plan patients spending 2.5 to 5 times more than PPO patients shows that a retained patient base also raises revenue quality.
The key point is the referral chain. Documented examples show a single dental patient can carry up to $60,000 of total value together with three referrals. A lost patient represents more than just their own procedures; it also means losing related revenue that may have followed in the future.
5. The Invisible Costs of Patient Loss
Patient loss is usually calculated only through the revenue of the missed visit. But there are serious invisible costs beyond that: marketing spend for re-acquisition, administrative onboarding, the burden of learning the new patient's story from scratch, and the potential referral flow lost to competitors.
Data shows that after a poor experience, 44% of U.S. consumers move to a competitor and 67% tend to end the relationship entirely. Despite this, only 16% of businesses prioritise retention strategy. This suggests that the sector's fundamental problem is not only churn but noticing churn too late.
In healthcare, patient loss unfolds quietly. It does not appear on the new-appointment screen and is not immediately visible in short-term occupancy metrics. But its cumulative effect is substantial. Communication gaps, lack of follow-up, poor customer experience and general dissatisfaction are the core factors accelerating this loss.
Conclusion
The data points in a clear direction: patient retention is not a secondary loyalty issue for healthcare organisations; it is one of the structural levers at the heart of profitability. New patient acquisition is expensive, the probability of a second visit is low, and churn rates often exceed growth rates. In contrast, a retained patient carries a higher return probability, a higher lifetime value and a stronger referral potential.
For this reason, reading clinical profitability solely through new patient counts provides an incomplete framework. The real question is how many of the acquired patients can be preserved, and how much of that relationship can be turned into long-term value. The retention strategy may look less exciting on the surface; but it is one of the most efficient and most neglected areas of long-term growth.